Abstract: Provided are compounds of Formula Ir(LA)x(LC)y wherein: ligand LA has Formula I? ?and ligand LC has Formula II?

Abstract: A compound comprising a ligand LA of Formula I, where G has a structure of is disclosed. In ligand LA, Ring C is a 5-membered or 6-membered ring; K is a direct bond, O, or S; when K is O or S, X6 is C; each of RA, RB, and RC is H or a substituent, and can be joined together to form a ring; each of X1 to X6 is independently C or N; X1 is C if it is connected to ring C; the RB substituents of at least two adjacent ones of X2 to X5 are joined to form a ring; and the ligand LA is complexed to Ir through the two indicated dash lines to form a 5-membered chelate ring. Organic light emitting devices, consumer products, formulations, and chemical structures containing the compounds are also disclosed.

Abstract: The present disclosure provides compound having a first ligand LA, including those comprising a structure of Formula A, In the compound, each of X1P to X6P is C, N, or B, where at least one of X1P to X6P is N or B; at least four substituent pairs selected from (R1, R2), (R2, R3), (R3, R4), (R4, R5), (R5, R6), and (R6, R1) are joined or fused together to form rings fused to the center ring P; each of R1, R2, R3, R4, R5, and R6 is independently a hydrogen or a General Substituents defined herein; LA is coordinated to a metal M to form a 5-membered or 6-membered chelate ring; and any two substituents may be joined or fused to form a ring. Formulations, OLEDs, and consumer products containing such compounds are also provided.

Abstract: A compound having a first ligand LA including a structure of Formula I, is provided. In Formula I, each of moiety B and moiety D is a monocyclic ring or a polycyclic fused ring system; each of X1 to X5 is C or N; ring C is bonded to ring A by a C; K is a direct bond or a linking group; each RA, RB, RC, and RD is hydrogen or a General Substituent defined herein; at least one RC or RD comprises an electron-withdrawing group; and LA is coordinated to a metal M through the dashed lines. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound of Formula Ir(LA)x(LB)(LC)z is provided, where LA comprises a structure of Formula I, and each of LB and LC is a different bidentate ligand. In the compounds of Formula Ir(LA)x(LB)(LC)z, where moiety A is a polycyclic fused ring system comprising at least three rings, including at least one non-benzene ring; moiety B is a monocyclic ring or a polycyclic fused ring system; each of X1, X2, and Z1 is C or N; the Ir—C1 bond is a metal-carbene bond; Y1 is a linker; L1 is a direct bond or a linker; K1 is a direct bond or a linker; and each RA and RB is hydrogen or a general Substituent defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are organometallic compounds comprising a ligand which is at least a two-dentate ligand which comprises at least one 5-membered nitrogen containing heterocyclic ring, the nitrogen of which is bonded to the central metal atom. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: Provided are organometallic compounds comprising a ligand which is at least a two-dentate ligand which comprises at least one 5-membered nitrogen containing heterocyclic ring, the nitrogen of which is bonded to the central metal atom. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: A compound comprising a first ligand LA of Formula I?, or Formula I*: In Formula I? or Formula I*, all the variables are defined herein; and LA is coordinated to a metal M. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are neutral Pt or Pd compounds comprising a tridentate and a monodentate ligand, wherein the tridentate ligand comprises at least three 5- or 6-membered rings. Also provided are formulations comprising these neutral Pt or Pd compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these neutral Pt or Pd compounds.

Abstract: Provided are organometallic complexes including 5-membered heterocyclic rings. The compounds include a ligand LA having a structure of Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: A compound of Formula I wherein Y is selected from the group consisting of NAr, O, S, and Se; Ar is an optionally substituted aryl or optionally substituted heteroaryl; and Z1 to Z8 are independently selected from C or N, wherein at least one of Z2 or Z3 is C, and at least one of Z6 or Z7 is C. R is selected from the group consisting of deuterium, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof; or optionally R can join with Ar to from a ring; and with the provisios that R is not N-methyl-benzimidazole, and the compound is not compound A.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are compounds of Formula Ir(LA)x(LC)y wherein: ligand LA has Formula I? ?and ligand LC has Formula II?

Abstract: A compound including a ligand LA of Formula I, where C1 and C2 are carbon atoms and a moiety of Formula II, is bonded to one of C1 and C2 by the two dashed lines in Formula II is provided. The variables in Formulae I and II are as defined in the present disclosure.

Abstract: A compound of Formula I having isoindoline moiety is disclosed. Their unique configuration of the fused rings enable the compound to exhibit phosphorescent emission in red color region to near infrared region and are useful as emitter materials in organic electroluminescence device.

Abstract: Provided are compounds of Formula Ir(LA)x(LC)y, wherein: ligand LA has Formula I? and ligand LC has Formula II?

Abstract: A compound having a first ligand LA of Formula I, is provided. In Formula I, Z is C or N; at least one of X1 to X5 is N, and the remainder are C; if X1 is N, then X5 is C; K is selected from the group consisting of a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); each R?, R?, RA and RB is a hydrogen or a General Substituent; LA is coordinated to a metal M; and Ring A coordinates to M through a metal carbene bond. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are compounds compound comprising a first ligand LA of Formula I: wherein R1 and R2 are each independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein LA is coordinated to a metal M through the indicated dashed lines; wherein M may be coordinated to other ligands; wherein LA may be joined with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and wherein any two substituents may be joined or fused to form a ring. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: Provided are organometallic compounds comprising a ligand with fused aromatic structures according to Formula I as described herein and their various uses including as emitters in devices and related electronic devices. Also provided are formulations comprising these compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these compounds.

Abstract: This invention relates to the development of heterocyclic materials for use as blue phosphorescent materials in OLED devices. The materials are based on a pair of 5-membered aromatic or psuedoaromatic rings bonded to one another and complexed to a transition metal. The materials were determined computationally to have appropriate triplet energies for use as blue emitters and to possess sufficient chemical stability for use in devices.